menu

Blizard Institute

Staff menu

Zahidul Quayyum

Zahidul

Email: z.quayyum@qmul.ac.uk
Telephone: 020 7882 2524

Profile

Zahidul Quayyum joined PCTU, Centre for Primary Care and Public Health, Blizard Institute in October 2016. Prior to joining PCTU, he was working with HEHTA, University of Glasgow and was working with Global Health Technology Assessment Groups and was involved in within trial cost-effectiveness analysis of health care intervention and technology assessment. Before joining University of Glasgow he was working with HERU, University of Aberdeen, where he was working with the Assessment of Health Technology Group and was engaged in conducting research for a number of technology assessment reviews and modelling for economic evaluation. At the University of Aberdeen, he also worked as a Health Economist for an international project called IMMPACT, and was mainly involved in working on economic evaluation models for safe motherhood interventions strategies and the economic analysis of interventions on improving maternal and child health in low and middle income countries.

His research interests include global health - maternal and child health in particular; economic evaluation and health care technology assessment of maternal and child health interventions, inequality in maternal and child health, and allocation of health care resources.

Summary

Zahidul Quayyum holds a first degree in Economics from University of Dhaka, Bangladesh; an MA degree in Economics from Thammasat University, Bangkok, Thailand; and an MSc in Health Policy Planning and Financing from London School of Hygiene and Tropical Medicine, UK. He undertook his PhD in Health Economics at the University of Aberdeen.

Teaching

Teaching Health Economics to BSc Global Health students
 

Research

Research Interests:

Currently working on a Project on Economic Impact of Stroke in the UK : now and in the future with a predicted reduction in cost burden by investment in stroke research.

Recent Research Projects include:

  1. Culprit Lesion only PCI with stage non-culprit revascularization vs. Immediate multi-vessel revascularization by PCI in patients with acute myocardial infarction complicated by cardiogenic shock- A Multi-country trial.- Developed the Health Economics Analysis Plan and development of thee decision model.
  2. A prospective feasibility study to compare patient reported outcomes, health service utilisation and place of care/death between patients with advanced heart failure attending a palliative cardiology clinic and a control group of those receiving usual care. – Analyses of patient level data on cost-effectiveness analysis
  3. Clinical Effectiveness and cost-effectiveness of imatinib at escalated doses of 600 mg/day or 800 mg/day for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours which have progressed on treatment at a dose of 400 mg/day.
  4. Systematic review of the clinical and cost-effectiveness of rapid point of care test for the detection of genital Chlamydia in women and men.
  5. An assessment of the cost-effectiveness of magnetic resonance, including diffusion-weighted imaging, in patients with transient ischaemic attack and minor stroke: a systematic review, meta-analysis and economic evaluation.
  6. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation.
  7. Economic burden of intracranial vascular malformations in adults: prospective, population-based study.
Research Interests: Economic Evaluation and Decision Modelling for Health Technology Assessment, Global Health, Health Systems and Financing, Resource Allocation in Health Care, Maternal and Child Health  

Publications

  1. Wardlaw J, Brazzelli M, Miranda H, Chappell F, McNamee P, Scotland G, Quayyum Z, Martin D, Shuler K, Sandercock P, Dennis M (2014). An assessment of the cost-effectiveness of magnetic resonance, including diffusion-weighted imaging, in patients with transient ischaemic attack and minor stroke: a systematic review, meta-analysis and economic evaluation. Health Technology Assessment. Apr; 18(27):1-368.
  2. Brazzelli M, Shuler K, Quayyum Z, Hadley D, Muir K, McNamee P, De Wilde J,0 Dennis M, Sandercock P, Wardlaw JM (2013). Clinical and imaging services for TIA and minor stroke: results of two surveys of practice across the UK. BMJ Open. 2013 Aug 7;3(8). doi: 10.1136/bmjopen-2013-003359
  3. Can community level intervention have impact on equity and utilization of maternal health care" - Evidence from Rural Bangladesh. Quayyum, Z., Khan M N U., Quayyum, T. Nasreen, H.E., Chowdhury, M. and Ensor, T. International Journal for Equity in Health 2013, 12:22. p 1-13.
  4. Clinical Effectiveness and cost-effectiveness of imatinib at escalated doses of 600 mg/day or 800 mg/day for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours which have progressed on treatment at a dose of 400 mg/day. Hislop J, Quayyum Z, Elders A, Fraser C, Jenkinson D, Mowatt G, Sharma P, Vale L, Petty R. Health Tech Ass 2011; Vol. 15: No 2.
  5. Systematic review of the clinical and cost-effectiveness of rapid point of care test for the detection of genital Chlamydia in women and men. Jennifer, H., Quayyum, Z. Flett, G, Boachie, C., Fraser, C., Mowett G. Health Tech Ass. Vol.14: No.29. 2010.
  6. Expenditure for obstetric care and effects of insurance on protecting poor mothers. Lessons from two districts in Indonesia. Quayyum Z, Nadjib, M, Ensor, T., and Sucahya, P.K. Paper published in Health Policy and Planning. 2010, May, 25 (3), p 237-47.
  7. The cost effectiveness of consistent and early intervention of harm reduction for injecting drug users in Bangladesh L Guinness, P Vickerman, Z Quayyum,  A Foss,  C Watts,  A Rodericks, T Azim,  S Jana, L Kumaranayake. Addiction.  2010 Feb, 105 (2); p 319-28.
  8. Level and determinants of incentives for village midwives in Indonesia”, Tim Ensor, Zahidul Quayyum, Mardiati Nadjib and Purwa Sucahya. Health Policy and Planning. 2009, January; 24 (1): p. 26 - 35.
  9. Economic burden of intracranial vascular malformations in adults: prospective, population-based study. Clare E. Miller, Zahidul Quayyum, Paul McNamee, and Rustam Al-Shahi Salman. Stroke. 2009, June; 40 (6). p 1973-9. 
  10. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. Black C, Clar C, Henderson R, MacEachern C, McNamee P, Quayyum Z, Royle P, and Thomas S.. Health Tech Ass 2009; Vol. 13. No. 52.
  11. Public Funding for community based skilled delivery care in Indonesia – to what extent are the poor benefited”. Tim Ensor, Mardiati Nadjib, Zahidul Quayyum and Amila Megraini. European Journal of Health Economics. 2008:  9, p 385-392.
  12. "Maternal and Peri-natal Conditions." 2006. Disease Control Priorities in Developing Countries (2nd Edition),ed. , 499-530. New York: Oxford University Press. DOI: 10.1596/978-0-821-36179-5/Chpt-26. Wendy J. Graham, John Cairns, Sohinee Bhattacharya, Colin H. W. Bullough, Zahidul Quayyum, and Khama Rogo. The chapter inter alia studied the cost effectiveness of Maternal Health Intervention Strategies in South Asia and Sub-Saharan Africa and my contributions relates to this section of the chapter.
Return to top